Equine CK-MB antibody and antigen (recombinant protein)

Diagnostic anti-Equine CK-MB antibodies pairs and antigen for animal health (animal Equine/Horse Myocardial hypoxia) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-CK-MB-Ag01Equine CK-MB$3090.00
GMP-EQU-CK-MB-Ab01Anti-Equine CK-MB mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-CK-MB-Ab02Anti-Equine CK-MB mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-CK-MB-Ab03Anti-Equine CK-MB human monoclonal antibody (mAb)$3090.00
GMP-EQU-CK-MB-Ab04Anti-Equine CK-MB human monoclonal antibody (mAb)$3090.00

Size： 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-CK-MB-Ag01
Product NameEquine CK-MB
Target/BiomarkerEquine CK-MB
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine CK-MB antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CK-MB level test of animal Equine/Horse with Myocardial hypoxia.
TagHis
Reconized/Reactive SpecicsEquine CK-MB
Product descriptionRecombinant Equine CK-MB protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-CK-MB-Ab01,GMP-EQU-CK-MB-Ab02
Target/BiomarkerEquine CK-MB
Product NameAnti-Equine CK-MB mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine CK-MB antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CK-MB antibodies in Equine CK-MB level test of animal Equine/Horse with Myocardial hypoxia.
Product descriptionAnti-Equine CK-MB mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CK-MB antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-CK-MB-Ab03,GMP-EQU-CK-MB-Ab04
Target/BiomarkerEquine CK-MB
Product NameAnti-Equine CK-MB human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine CK-MB antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CK-MB antibodies in Equine CK-MB level test of animal Equine/Horse with Myocardial hypoxia.
Product descriptionAnti-Equine CK-MB mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Creatine Kinase-MB (CK-MB) in horses assumes a pivotal role as an enzyme biomarker with specific relevance to equine cardiology. It represents a subtype of the enzyme creatine kinase (CK), which is integral to energy metabolism, particularly in tissues characterized by high-energy demands, such as skeletal and cardiac muscle.

    In equines, CK-MB is primarily situated within cardiac muscle cells, making it a highly specific marker for assessing cardiac health. It comprises various isoforms, with the cardiac isoform CK-MB being the dominant variant in equine hearts. This specific localization of CK-MB within cardiac muscle renders it an accurate indicator of myocardial status in horses.

    When the heart muscle in horses experiences injury or stress, CK-MB is released into the bloodstream, where it becomes quantifiable. This release mechanism forms the foundation for employing CK-MB as an indicator of myocardial damage in equines. The measurement of CK-MB levels plays a pivotal role in diagnosing various cardiac conditions and monitoring the response to treatment.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.